リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Temporal arteritis with focal pachymeningitis: a deceptive association」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Temporal arteritis with focal pachymeningitis: a deceptive association

Raja K Kutty Maekawa, Michitaka Kawase, Tsukasa Fujii, Naoko Kato, Yoko 名古屋大学

2020.02

概要

Temporal arteritis is an immunological disorder mostly affecting the elderly population. This frequently occurs in association with other rheumatological diseases of the elderly. The symptoms of Temporal arteritis overlap with other symptoms of commonly occurring diseases in that population. Focal pachymeningitis in association with temporal arteritis is a rare finding and a literature review revealed less than ten cases of similar associations being published. In such instances, this finding can be mistaken for aseptic meningitis and treated erroneously. We present our case, discuss the management and summarize a review of literature about focal pachymeningitis along with temporal arteritis which was managed successfully with steroids and Toclizumab.

この論文で使われている画像

参考文献

1) Cho HJ, Bloomberg J, Nichols J. Giant cell arteritis. Dis Mon. 2017;63(3):88–91.

2) Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the

classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–1128.

3) Watelet B, Samson M, de Boysson H, Bienvenu B. Treatment of giant-cell arteritis, a literature review.

Mod Rheumatol. 2017;27(5):747–754.

4) Kobayashi S, Yano T, Matsumoto Y, et al. Clinical and epidemiologic analysis of giant cell (temporal)

arteritis from a nationwide survey in 1998 in Japan: The first government-supported nationwide survey.

Arthritis Rheum. 2003;49(4):594–598.

5) Dinesh KP, Owolabi A, Dwyer-Joyce L, Cronin PM, Schimmer BM, Mo GP. Temporal artery vasculitis in

young: a report of two cases. Rheumatol Int. 2010;30(10):1393–1396.

6) Dogra M, Singh R, Dogra MR. Giant cell arteritis related arteritic anterior ischemic optic neuropathy:

clinico-pathological correlation. Indian J Ophthalmol. 2019;67(1):142.

7) Yoon HJ, Park SW, Lee HK, Choi YD, Heo H. Bilateral arteritic anterior ischemic optic neuropathy

associated with giant cell arteritis in Korea. Korean J Ophthalmol. 2017;31(5):466.

8) Skanchy DF, Vickers A, Claudia M, Ponce P, Lee AG. Ocular manifestations of giant cell arteritis. Expert

Rev Ophthalmol. 2019;14(1):23–32.

149

Giant cell arteritis with focal pachymeningitis

9) Zachariades N, Skoura C, Spanou A, Machera H. Temporal arteritis: report of a case. Oral Surgery Oral

Med Oral Pathol Oral Radiol Endod. 2006;102(2):192–197.

10) Thurtell MJ, Longmuir RA. Third nerve palsy as the initial manifestation of giant cell arteritis. J Neuroophthalmology. 2014;34(3):243–245.

11) Gerstle CC, Friedman AH. Marginal corneal ulceration (limbal guttering) as a presenting sign of temporal

arteritis. Ophthalmology. 1980;87(11):1173–1176.

12) Hsu YW, Yang FC, Lee JT, Kao HW, Tsai CK. Orbital cellulitis presenting as giant cell arteritis: a case

report. Acta Neurol Taiwan. 2017;26(2):72–75.

13) Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the

United Kingdom, 1990–2001. Ann Rheum Dis. 2006;65(8):1093–1098.

14) Elling P, Olsson AT, Elling H. Synchronous variations in the incidence of temporal arteritis and polymyalgia

rheumatica in Danish counties. Association with epidemics of Mycoplasma pneumonia infection [in Danish].

Ugeskr Laeger. 1997;159(26):4123–4128.

15) Joelson E, Ruthrauff B, Ali F, Lindeman N, Sharp FR. Multifocal dural enhancement associated with

temporal arteritis. Arch Neurol. 2000;57(1):119–122.

16) Marano E, D’Armiento FP, Scarano V, Tortora F, Mignogna C, Briganti F. Focal hypertrophic cranial

pachymeningitis associated with temporal arteritis: a new case report. J Neurol. 2003;250(1):98–100.

17) Brass SD, Durand ML, Stone JH, Chen JW, Stone JR. Case 36-2008: a man with chronic daily headache.

N Engl J Med. 2008;359(21):2267–2278.

18) Kuhn J, Harzheim A, Brockmann M, Mahkorn D, Bewermeyer H. Focal hypertrophic pachymeningitis in

association with temporal arteritis. Headache. 44(10):1045–1048.

19) Tokushige S, Matsuura H, Hideyama T, Tamura K, Maekawa R, Shiio Y. Hypertrophic pachymeningitis as

a potential cause of headache associated with temporal arteritis. Intern Med. 2016;55(5):523–526.

20) Uribe JA, Aggarwal I, Witthayaweerasak J, Liao YJ, Berry GJ, Sab UK. Weynad CM.Refractory giant cell

arteritis complicated by vision loss from optic atrophy and maculopathy associated with pachymeningitis.

J Neurophthalmol. 2018;38(1):17–23.

21) Gordon M, Gordon EP. Temporal arteritis: cerebrospinal fluid and brain scan abnormalities (case report).

J Am Geriatr Soc. 1980;28(3):136–138.

22) Roelcke U, Eschle D, Kappos L, Moschopulos M, Laeng RH, Buettner UW. Meningoradiculitis associated

with giant cell arteritis. Neurology. 2002;59(11):1811–1812.

23) Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries.

Arthritis Rheum. 2006;55(6):985–989.

24) Larivière D, Sacre K, Klein I, et al. Extra- and intracranial cerebral vasculitis in giant cell arteritis. Medicine

(Baltimore). 2014;93(28):e265.

25) Alsolaimani RS, Bhavsar SV, Khalidi NA, et al. Severe intracranial involvement in giant cell arteritis: 5

cases and literature review. J Rheumatol. 2016;43(3):648–656.

26) Kargiotis O, Safouris A, Petrou VN, Magoufis G, Stamboulis E, Tsivgoulis G. Teaching Neuro Images:

giant cell arteritis presenting with acute ischemic strokes due to diffuse intracranial stenoses. Neurology.

2017;89(15):e190–e191.

27) Kudo T, Yoshinaga K, Takeishi Y, Nakajima K. Statement on 18F-FDG PET usage for large-vessel vasculitis.

Ann Nucl Cardiol. 2018;4(1):46–51.

28) Allsop CJ, Gallagher PJ. Temporal artery biopsy in giant-cell arteritis: a reappraisal. AmJSurgPathol.

1981;5(4):317–323.

29) Borchers AT, Gershwin ME. Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology

and treatment. Autoimmun Rev. 2012;11(6–7):A544–A554.

30) Breuer GS, Nesher R, Nesher G. Negative temporal artery biopsies: eventual diagnoses and features of

patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol.

2008;26(6):1103–1106.

31) Bowling K, Rait J, Atkinson J, Srinivas G. Temporal artery biopsy in the diagnosis of giant cell arteritis:

does the end justify the means? Ann Med Surg(Lond). 2017;20:1–5.

32) Achkar AA, Lie JT, Hunder GG, O’Fallon WM, Gabriel SE. How does previous corticosteroid treatment

affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med.1994;120(12):987–982.

33) Narváez J, Bernad B, Roig-Vilaseca D, et al. Influence of previous corticosteroid therapy on temporal artery

biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007;37(1):13–19.

34) Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: an

individual patient data meta-analysis. Arthritis Rheum. 2007;56(8):2789–2797.

35) Fytili C, Bournia VK, Korkou C, Pentazos G, Kokkinos A. Multiple cranial nerve palsies in giant cell

150

Raja K Kutty et al

arteritis and response to cyclophosphamide: a case report and review of the literature. Rheumatol Int.

2015;35(4):773–776.

36) Imrich R, Bosak V, Rovensky` J. Polymyalgia rheumatica and giant cell arteritis. Endocr Regul.

2006;40(3):63–69.

37) Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med.

2017;377(4):317–328.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る